Related references
Note: Only part of the references are listed.Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice
G. Martella et al.
NEUROBIOLOGY OF DISEASE (2016)
Neuronal hyperactivity - A key defect in Alzheimer's disease?
Marc Aurel Busche et al.
BIOESSAYS (2015)
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
Joao P. L. Daher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model
Alevtina D. Zharikov et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Balancing the basal ganglia circuitry: A possible new role for dopamine D2 receptors in health and disease
Maxime Cazorla et al.
MOVEMENT DISORDERS (2015)
Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
M. Yue et al.
NEUROBIOLOGY OF DISEASE (2015)
An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene-environment interactions
Michaela E. Johnson et al.
NEUROTOXICOLOGY (2015)
Impaired intracellular trafficking defines early Parkinson's disease
Benjamin H. M. Hunn et al.
TRENDS IN NEUROSCIENCES (2015)
Interneuronal Nitric Oxide Signaling Mediates Post-synaptic Long-Term Depression of Striatal Glutamatergic Synapses
Igor V. Rafalovich et al.
CELL REPORTS (2015)
LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory
Dayne A. Beccano-Kelly et al.
HUMAN MOLECULAR GENETICS (2015)
Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), A Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor
Jaclyn L. Henderson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers
Rick C. Helmich et al.
NEUROLOGY (2015)
Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis
Karina J. Vargas et al.
JOURNAL OF NEUROSCIENCE (2014)
Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles through Protein Interactions Mediated by Its C-Terminal WD40 Domain
Giovanni Piccoli et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
The role of the LRRK2 gene in Parkinsonism
Jie-Qiong Li et al.
MOLECULAR NEURODEGENERATION (2014)
PINK1 Heterozygous Mutations Induce Subtle Alterations in Dopamine-Dependent Synaptic Plasticity
Graziella Madeo et al.
MOVEMENT DISORDERS (2014)
Lazy Nigrostriatal Synapses in the Heterozygous PINK1 Mouse Model of Familial Parkinson's Disease
Paolo Calabresi et al.
MOVEMENT DISORDERS (2014)
LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity
Loukia Parisiadou et al.
NATURE NEUROSCIENCE (2014)
Direct and indirect pathways of basal ganglia: a critical reappraisal
Paolo Calabresi et al.
NATURE NEUROSCIENCE (2014)
Basal ganglia subcircuits distinctively encode the parsing and concatenation of action sequences
Xin Jin et al.
NATURE NEUROSCIENCE (2014)
Extracellular α-synuclein-a novel and crucial factor in Lewy body diseases
He-Jin Lee et al.
NATURE REVIEWS NEUROLOGY (2014)
Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse
Tonya N. Taylor et al.
NEUROBIOLOGY OF DISEASE (2014)
Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
William A. Toy et al.
NEUROBIOLOGY OF DISEASE (2014)
Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease
Kuldip D. Dave et al.
NEUROBIOLOGY OF DISEASE (2014)
Dopamine D2 Receptors Regulate the Anatomical and Functional Balance of Basal Ganglia Circuitry
Maxime Cazorla et al.
NEURON (2014)
Parkin and PINK1: much more than mitophagy
Leslie A. Scarffe et al.
TRENDS IN NEUROSCIENCES (2014)
Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
Dayne A. Beccano-Kelly et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats
Padraig Mulcahy et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Concurrent activation of striatal direct and indirect pathways during action initiation
Guohong Cui et al.
NATURE (2013)
Advances in the genetics of Parkinson disease
Joanne Trinh et al.
NATURE REVIEWS NEUROLOGY (2013)
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model
Stephanie Janezic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The enemy within: propagation of aberrant corticostriatal learning to cortical function in Parkinson's disease
Jeff A. Beeler et al.
FRONTIERS IN NEUROLOGY (2013)
Early, severe and bilateral loss of LTP and LTD-like plasticity in motor cortex (M1) in de novo Parkinson's disease
Asha Kishore et al.
CLINICAL NEUROPHYSIOLOGY (2012)
Considerations Regarding the Etiology and Future Treatment of Autosomal Recessive Versus Idiopathic Parkinson Disease
Tohru Kitada et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2012)
Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
Maria Jose Diogenes et al.
JOURNAL OF NEUROSCIENCE (2012)
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
Jacqueline Burre et al.
JOURNAL OF NEUROSCIENCE (2012)
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice
Alessandro Tozzi et al.
NEUROBIOLOGY OF AGING (2012)
LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis
Samer Matta et al.
NEURON (2012)
ABERRANT STRIATAL SYNAPTIC PLASTICITY IN MONOGENIC PARKINSONISMS
G. Madeo et al.
NEUROSCIENCE (2012)
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons
Martin Lundblad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
An extracellular mechanism that can explain the neurotoxic effects of alpha-synuclein aggregates in the brain
C. Pacheco et al.
FRONTIERS IN PHYSIOLOGY (2012)
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
He-Jin Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
PARAQUAT- AND ROTENONE-INDUCED MODELS OF PARKINSON'S DISEASE
R. Nistico et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool
Giovanni Piccoli et al.
JOURNAL OF NEUROSCIENCE (2011)
Elevated Tonic Extracellular Dopamine Concentration and Altered Dopamine Modulation of Synaptic Activity Precede Dopamine Loss in the Striatum of Mice Overexpressing Human α-Synuclein
Hoa A. Lam et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
A Tale on Animal Models of Parkinson's Disease
Erwan Bezard et al.
MOVEMENT DISORDERS (2011)
The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
E. Ilijic et al.
NEUROBIOLOGY OF DISEASE (2011)
Synaptopathy: dysfunction of synaptic function?
Nils Brose et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
α-Synuclein Transgenic Mice Reveal Compensatory Increases in Parkinson's Disease-Associated Proteins DJ-1 and Parkin and Have Enhanced α-Synuclein and PINK1 Levels After Rotenone Treatment
Sonia George et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
LRRK2 Kinase Regulates Synaptic Morphology through Distinct Substrates at the Presynaptic and Postsynaptic Compartments of the Drosophila Neuromuscular Junction
Seongsoo Lee et al.
JOURNAL OF NEUROSCIENCE (2010)
Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
Xianting Li et al.
JOURNAL OF NEUROSCIENCE (2010)
Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
Evangelia Emmanouilidou et al.
JOURNAL OF NEUROSCIENCE (2010)
Distinct Levels of Dopamine Denervation Differentially Alter Striatal Synaptic Plasticity and NMDA Receptor Subunit Composition
Vincent Paille et al.
JOURNAL OF NEUROSCIENCE (2010)
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
H. L. Melrose et al.
NEUROBIOLOGY OF DISEASE (2010)
Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit
C. Eggers et al.
NEUROLOGY (2010)
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
Venu M. Nemani et al.
NEURON (2010)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys
Rosa M. Villalba et al.
EXPERIMENTAL NEUROLOGY (2009)
LRRK2 in Parkinson's disease: genetic and clinical studies from patients
Udhaya Kumari et al.
FEBS JOURNAL (2009)
Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease
Katerina Venderova et al.
HUMAN MOLECULAR GENETICS (2009)
Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila
Chee-Hoe Ng et al.
JOURNAL OF NEUROSCIENCE (2009)
Mapping Preclinical Compensation in Parkinson's Disease: An Imaging Genomics Approach
Bart F. L. van Nuenen et al.
MOVEMENT DISORDERS (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
α-Synuclein and LRRK2: Partners in Crime
Youren Tong et al.
NEURON (2009)
Striatal spine plasticity in Parkinson's disease: pathological or not?
Y. Smith et al.
PARKINSONISM & RELATED DISORDERS (2009)
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Animal models of Parkinson's disease progression
Gloria E. Meredith et al.
ACTA NEUROPATHOLOGICA (2008)
Genomic investigation of α-synuclein multiplication and parkinsonism
Owen A. Ross et al.
ANNALS OF NEUROLOGY (2008)
Motor Cortical Physiology in Patients and Asymptomatic Carriers of Parkin Gene Mutations
Susanne A. Schneider et al.
MOVEMENT DISORDERS (2008)
Striatal and extrastriatal dopamine in the basal ganglia: An overview of its anatomical organization in normal and Parkinsonian brains
Yoland Smith et al.
MOVEMENT DISORDERS (2008)
Parkinson's disease and pesticides: a toxicological perspective
Jaime M. Hatcher et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers -: A TMS study
T. Baeumer et al.
NEUROLOGY (2007)
The roles of kinases in familial Parkinson's disease
Mark R. Cookson et al.
JOURNAL OF NEUROSCIENCE (2007)
Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice
Tohru Kitada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
Christine Klein et al.
LANCET NEUROLOGY (2007)
Dopamine-mediated regulation of corticostriatal synaptic plasticity
Paolo Calabresi et al.
TRENDS IN NEUROSCIENCES (2007)
Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies
Michael L. Kramer et al.
JOURNAL OF NEUROSCIENCE (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: Oxidation of thioredoxin and caspase-3 activation
Sampath Ramachandiran et al.
TOXICOLOGICAL SCIENCES (2007)
Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism
Ariel Y. Deutch et al.
PARKINSONISM & RELATED DISORDERS (2007)
Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes
Neeta S. Roy et al.
NATURE MEDICINE (2006)
Changes in suhcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and L-dopa-treated rats
Maowen Ba et al.
NEUROCHEMICAL RESEARCH (2006)
Synaptic vulnerability in neurodegenerative disease
Thomas M. Wishart et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Timing of treatment initiation in Parkinson's disease: A need for reappraisal?
AHV Schapira et al.
ANNALS OF NEUROLOGY (2006)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Striatal synaptic plasticity: Implications for motor learning and Parkinson's disease
A Pisani et al.
MOVEMENT DISORDERS (2005)
Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity
R Hilker et al.
ARCHIVES OF NEUROLOGY (2005)
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease
S Zaja-Milatovic et al.
NEUROLOGY (2005)
Evidence of a breakdown of corticostriatal connections in Parkinson's disease
B Stephens et al.
NEUROSCIENCE (2005)
Trypsin disrupts the trafficking of the human dopamine transporter by α-synuclein and its A30P mutant
C Wersinger et al.
BIOCHEMISTRY (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Role of α-synuclein in presynaptic dopamine recruitment
L Yavich et al.
JOURNAL OF NEUROSCIENCE (2004)
Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP
R Betarbet et al.
EXPERIMENTAL NEUROLOGY (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
The role of α-synuclein in Parkinson's disease:: Insights from animal models
E Maries et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated
E Bezard et al.
TRENDS IN NEUROSCIENCES (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Repetitive magnetic stimulation of cortical motor areas in Parkinson's disease:: Implications for the pathophysiology of cortical function
F Gilio et al.
MOVEMENT DISORDERS (2002)
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model
LM Björklund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Synaptic organisation of the basal ganglia
JP Bolam et al.
JOURNAL OF ANATOMY (2000)
Membrane association and protein conformation of α-synuclein in intact neurons -: Effect of Parkinson's disease-linked mutations
PJ McLean et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
